CN209808729U - 一种新型蒸汽眼罩 - Google Patents
一种新型蒸汽眼罩 Download PDFInfo
- Publication number
- CN209808729U CN209808729U CN201920037828.2U CN201920037828U CN209808729U CN 209808729 U CN209808729 U CN 209808729U CN 201920037828 U CN201920037828 U CN 201920037828U CN 209808729 U CN209808729 U CN 209808729U
- Authority
- CN
- China
- Prior art keywords
- cover body
- eye
- layer
- freeze
- shade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 14
- 230000004888 barrier function Effects 0.000 claims abstract description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- 238000004026 adhesive bonding Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 210000003934 vacuole Anatomy 0.000 claims description 2
- 239000004744 fabric Substances 0.000 abstract description 54
- 239000012528 membrane Substances 0.000 abstract description 46
- 238000004108 freeze drying Methods 0.000 abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 17
- 238000010438 heat treatment Methods 0.000 abstract description 14
- 208000003464 asthenopia Diseases 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 21
- 239000000126 substance Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 14
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 9
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 9
- 229940022757 asiaticoside Drugs 0.000 description 9
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 3
- 101800003838 Epidermal growth factor Proteins 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229940116977 epidermal growth factor Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002740 effect on eyes Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000021062 nutrient metabolism Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
本实用新型公开了一种新型蒸汽眼罩。它包括眼罩本体和发热体,所述的眼罩本体包括罩体和连接在罩体两侧的左罩带和右罩带,所述的罩体包括相连在一起的左罩体和右罩体,所述的左罩体和右罩体结构相同,其包括内侧的冻干膜布层和外侧的无纺布层,冻干膜布层和外侧的无纺布层周侧相连接,形成空腔,在空腔内设有固定袋,在固定袋中设有发热体,所述的固定袋靠近冻干膜布层的是透气透湿层,靠近无纺布层的湿气阻隔层。发热体与空气接触时,可释放蒸汽并保持41℃恒温,然后再加热冻干膜布,使得冻干膜布中的水变成蒸汽,作用于眼部,可改善眼部血液循环,缓解眼部疲劳等。
Description
技术领域:
本实用新型属于眼部护肤技术领域,特别涉及一种可明显缓解眼部疲劳、淡化黑眼圈、抗衰老的新型蒸汽眼罩。
背景技术:
随着科技的发展,电脑、手机等电子产品充实到我们生活的各个角落,长期使用电子产品、睡眠不足或用眼过度造成的眼部疲劳、视力模糊、眼睛干涩、黑眼圈、眼袋等症状开始频繁出现在我们生活中。眼睛是心灵的窗户,随着人们生活质量的提高,对眼部健康已经逐渐重视,各种眼部护理产品如护眼罩、眼贴、眼霜等开始出现。如市场上出现的蒸汽眼罩产品,它是利用铁粉氧化发热原理,使眼罩产生温热蒸汽,对眼部进行热敷,可使皮肤毛孔张开,血管扩张,促进血液流向表皮,使皮肤变得柔软而细腻,从而减轻或缓解眼部各种问题。
冻干膜布是利用全新的冻干技术,在低温环境下,让膜布里功效物质中液态水份变成固体冰晶,然后通过真空控温使固体冰晶变成气态升华,从而形成不含水分的冻干膜布,在使用时只需将膜布用水浸湿即可。此技术无需添加防腐剂,无刺激,对皮肤温和,更安全;在低温下干燥,功效物质更稳定,其活性更容易发挥。
各类护肤产品如冻干膜布中会添加积雪草苷、透明质酸、寡肽-1等功效物质对眼部进行护理。积雪草苷能加快细胞增殖,加速伤口愈合,有修复疤痕功效,还能促进纤维蛋白再生,紧致表皮与真皮的连接部分,使皮肤光滑、紧致。透明质酸被称为理想的天然保湿因子,它可以改善皮肤营养代谢,使皮肤柔嫩、光滑、防止衰老。寡肽-1又叫表皮生长因子(EGF),它能促进皮肤和粘膜创伤的愈合,消炎镇痛,防治溃疡;还能有效地抑制粉刺和青春痘的生长。
有研究表明功效物质在加热条件下效果更佳。Garidel P.认为皮肤温度高于正常温度1℃就能使化妆品中功效物质吸收增加10倍。其原理是角质层中脂质成分随温度的升高会发生相转变,相变发生后脂质成分无序性增加,功效物质透过皮肤的渗透量也随之增加,从而促进皮肤对功效物质的吸收。(Garidel P.Structural organisation and phasebehaviour of astratum corneum lipid analogue:ceramide 3A[J].Phys Chem ChemPhys,2006,8(19):2265-2275.)
发明内容:
本实用新型的目的是提供一种起到眼部热敷和眼部护理双重功效的新型蒸汽眼罩,该眼罩能够自动发热,热敷能促进眼部对功效物质的吸收,可明显缓解眼部疲劳、淡化黑眼圈、抗衰老。
本实用新型是通过以下技术方案予以实施的:
本实用新型的新型蒸汽眼罩,其特征在于,包括眼罩本体和发热体,所述的眼罩本体包括罩体和连接在罩体两侧的左罩带和右罩带,所述的罩体包括相连在一起的左罩体和右罩体,所述的左罩体和右罩体结构相同,其包括内侧的冻干膜布层和外侧的无纺布层,冻干膜布层和外侧的无纺布层周侧相连接,形成空腔,在空腔内设有固定袋,在固定袋中设有发热体,所述的固定袋靠近冻干膜布层的是透气透湿层,靠近无纺布层的是湿气阻隔层。
所述的发热体是发热可以产生温热蒸汽,同时可以加热冻干膜布层。优选为铁粉发热体,如为:按质量百分数计,包括还原铁粉:55%-70%,蛭石:4%-10%,木质炭粉:10%-20%,水:10%-25%,吸水树脂:0.5%-2%,氯化钠:4%-12%,各组份的重量百分比之和为100%。
所述的左罩带和右罩带是通过粘接与罩体连接。
所述的透气透湿层指的是能够透过氧气和水蒸汽的膜布,氧气可通过透气透湿层进入固定袋;透气透湿层透湿度为3000g/(m2·24h),固定袋内发热体发热时产生水蒸汽,在内外温度差值条件下,水蒸汽可由透气透湿层微孔扩散到外部。可以从佛山市厚海复合材料有限公司购买。
所述的湿气阻隔层指的是不能透过水蒸汽可透过氧气的膜布,具体可以为不透气打孔膜,用打孔的方式与透气透湿层配合来控制透气量,从而来控制发热体的温度。可以从佛山市厚海复合材料有限公司购买。
所述的冻干膜布(是指将面膜原液、增稠剂、保湿剂等成分,与膜布纤维融合,使用真空冷冻干燥,将水分进行升华,形成固态干膜形式的面膜)用于贴合眼睛,此膜布已广泛应用于面膜(即现有技术中的冻干面膜)中,贴合眼睛的第一层不使用无纺布。所述的冻干膜布优选为含积雪草苷、透明质酸和/或寡肽-1等功效物质的冻干膜布。蒸汽眼罩对眼睛起到热敷作用,眼罩上冻干膜布中的积雪草苷、透明质酸、寡肽-1等功效物质对眼部进行护理,尤为重要的是,蒸汽眼罩的热敷作用能促进如上功效物质的吸收,起到协同增效作用。将传统蒸汽眼罩和冻干膜布相结合,能使积雪草苷、透明质酸、寡肽-1等功效物质更好发挥护理作用。本新型蒸汽眼罩有眼部保健和眼部护肤的双重功效。
本实用新型用于贴合眼睛的第一层不设置无纺布,改为冻干膜布。冻干膜布中添加有积雪草苷、透明质酸、寡肽-1等功效物质,有修复受损肌肤,抗敏感,抗衰老,保湿的功效,且无防腐剂,减少肌肤负担。发热体发热可以使第一层冻干膜布中功效物质更快被眼部吸收。散发的蒸汽能缓解眼部疲劳,冻干膜布中功效物质能对眼部进行护理,两者结合有协同增效作用。此蒸汽眼罩可以同时达到眼部保健和眼部护肤的功效。
本实用新型的新型蒸汽眼罩是这样使用的:
使用前将冻干膜布喷上水至湿润,再将左罩带和右罩带分别挂在使用者的耳朵上,就可以使用。冻干膜布的添加成分有海藻糖、透明质酸钠、积雪草苷、蛋白胶原、甘草酸二钾,有修复受损肌肤,抗敏感,抗衰老的功效。发热片发热时,热量使冻干膜布中的功效物质能够更好地被眼部吸收,可明显缓解眼部疲劳、淡化黑眼圈、抗衰老。
因此,本实用新型的有益效果如下:
发热体与空气接触时,可释放蒸汽并保持41℃恒温,然后再加热冻干膜布,使得冻干膜布中的水变成蒸汽,作用于眼部,可改善眼部血液循环,缓解眼部疲劳等。
附图说明:
图1为新型蒸汽眼罩的结构示意图;
图2为图1的新型蒸汽眼罩中A-A向的剖视图;
附图标记汇总:
1-罩体;2-左罩带;3-右罩带;4-左罩体;5-右罩体;6-冻干膜布层;7-无纺布层;8-固定袋;9-发热体;10-透气透湿层;11-湿气阻隔层;12-粘接区。
具体实施方式:
以下实施例是对本实用新型的进一步说明,而不是对本实用新型的限制。
实施例1:
如图1所示,本实施例的新型蒸汽眼罩,包括眼罩本体和发热体9,所述的眼罩本体包括罩体1和连接在罩体两侧的左罩带2和右罩带3,所述的罩体包括相连在一起的左罩体4和右罩体5,左罩体4和右罩体5连接处为开口鼻梁缝,所述的左罩体和右罩体结构相同,都包括内侧的冻干膜布层6和外侧的无纺布层7,冻干膜布层和外侧的无纺布层周侧边缘相连接,形成空腔,在空腔内设有固定袋8,在固定袋中设有发热体9,所述的固定袋靠近冻干膜布层的是透气透湿层10,靠近无纺布层的湿气阻隔层11,透气透湿层和湿气阻隔层周侧边缘连接形成固定袋。
所述的发热体,按质量分数计,包括还原铁粉60%、蛭石5%、木质炭粉10%、高分子吸水树脂1%,氯化钠4%、水20%,将上述成分按其含量混合均匀,然后装入固定袋中。
所述的左罩带和右罩带是通过粘接(在左罩体的左侧和右罩体的右侧各有一个粘接区12)与罩体连接。
所述的冻干膜布层可以为蕾丝骨胶原冻干膜布,在使用时在膜布上面喷水至膜布浸湿,再将两根罩带分别挂在使用者的耳朵上,就可以使用。蕾丝骨胶原冻干膜布的添加成分有海藻糖、透明质酸钠、积雪草苷、蛋白胶原、甘草酸二钾,有修复受损肌肤,抗敏感,抗衰老的功效。发热片发热时,热量使冻干膜布的中功效物质能够更好地被眼部吸收。
所述的冻干膜布层可以为医美纱布修护冻干膜布,在使用时在膜布上面喷水至膜布浸湿,同时,也可根据肌肤问题选择不同功效的纯露喷在冻干膜布上,达到不同的效果。将两根罩带分别挂在使用者的耳朵上,就可以使用。医美纱布修护冻干膜布的添加成分有海藻糖、芦荟凝胶、积雪草苷、赤藓糖醇,可以舒缓过敏肌肤,消炎杀菌,解决干燥暗哑、缺乏光泽的问题。发热片发热时,热量使冻干膜布的中功效物质能够更好地被眼部吸收。
所述的冻干膜布层可以为EGF修护冻干膜布层,在使用时在膜布上面喷水至膜布浸湿,同时,也可根据肌肤问题选择不同功效的纯露喷在冻干膜布上,达到不同的效果。将两根罩带分别挂在使用者的耳朵上,就可以使用。EGF修护冻干膜布层的添加成分有EGF冻干粉,可以修护受损肌肤、抗衰老、抗敏感,深层补水,使肌肤水润嫩滑。发热片发热时,热量使冻干膜布的中功效物质能够更好地被眼部吸收。
Claims (3)
1.一种新型蒸汽眼罩,其特征在于,包括眼罩本体和发热体,所述的眼罩本体包括罩体和连接在罩体两侧的左罩带和右罩带,所述的罩体包括相连在一起的左罩体和右罩体,所述的左罩体和右罩体结构相同,其包括内侧的冻干膜布层和外侧的无纺布层,冻干膜布层和外侧的无纺布层周侧相连接,形成空腔,在空腔内设有固定袋,在固定袋中设有发热体,所述的固定袋靠近冻干膜布层的是透气透湿层,靠近无纺布层的是湿气阻隔层。
2.根据权利要求1所述的新型蒸汽眼罩,其特征在于,所述的发热体是铁粉发热体。
3.根据权利要求1或2所述的新型蒸汽眼罩,其特征在于,所述的左罩带和右罩带是通过粘接与罩体连接。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201920037828.2U CN209808729U (zh) | 2019-01-10 | 2019-01-10 | 一种新型蒸汽眼罩 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201920037828.2U CN209808729U (zh) | 2019-01-10 | 2019-01-10 | 一种新型蒸汽眼罩 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN209808729U true CN209808729U (zh) | 2019-12-20 |
Family
ID=68870885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201920037828.2U Active CN209808729U (zh) | 2019-01-10 | 2019-01-10 | 一种新型蒸汽眼罩 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN209808729U (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730088A (zh) * | 2021-06-11 | 2021-12-03 | 郑州市新视明科技工程有限公司 | 一种薄片型自发热体眼罩及其制备工艺 |
-
2019
- 2019-01-10 CN CN201920037828.2U patent/CN209808729U/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730088A (zh) * | 2021-06-11 | 2021-12-03 | 郑州市新视明科技工程有限公司 | 一种薄片型自发热体眼罩及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI641484B (zh) | Self-heating insulation film and application thereof | |
CN104146874B (zh) | 一种自发热保温面膜 | |
KR20050024435A (ko) | 이산화탄소 외용 투여장치 | |
CN104983646A (zh) | 夜用养护面膜液及其制备方法 | |
CN204106608U (zh) | 一种自发热保温面膜 | |
CN205758812U (zh) | 一种带加热的除湿抗菌敷料贴 | |
KR20090091365A (ko) | 피부 외용재, 및 그것을 사용한 외용 소양증 치료제 및 주름 제거 도구 | |
CN209808729U (zh) | 一种新型蒸汽眼罩 | |
CN209048420U (zh) | 一种可拉伸式穴位灸理疗贴 | |
CN111568640A (zh) | 一种新型自发热眼罩及制备工艺 | |
CN204815350U (zh) | 硫酸镁敷贴片 | |
CN105853252B (zh) | 一种用于皮肤热损伤的温敏水凝胶及其制备方法 | |
CN212281881U (zh) | 一种保湿型蒸汽眼罩 | |
CN209662201U (zh) | 一种穴位发热敷贴 | |
CN212067226U (zh) | 一种基于玻尿酸的防皱纹护肤面膜 | |
CN211096199U (zh) | 一种生物纤维面膜 | |
CN101172183A (zh) | 眼部美容方法及产品 | |
CN218165483U (zh) | 一种能护理眼周肌肤的纳米冻干膜蒸汽眼罩 | |
CN112691287A (zh) | 一种自发热肩颈贴 | |
CN219423335U (zh) | 一种热敷面膜贴 | |
CN219501585U (zh) | 一种带有屏障修复功能的神经酰胺面膜布 | |
CN214713027U (zh) | 具有美容功效的蒸汽眼罩 | |
CN211050311U (zh) | 一种自发热式壳聚糖与竹炭纤维多层面膜 | |
RU2311169C1 (ru) | Косметическая маска | |
CN210962607U (zh) | 一种蒸汽冻干膜布眼罩 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 510000, 7th and 8th floors, No. 102 Guangchen Road, Baiyun District, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU SANSEN HEALTH INDUSTRY TECHNOLOGY Co.,Ltd. Country or region after: China Address before: 510000, Building 15, Lailihong Industrial Park, No. 129 Xiusheng Road, Renhe Town, Baiyun District, Guangzhou City, Guangdong Province, China (self declared) Patentee before: GUANGZHOU SANSEN HEALTH INDUSTRY TECHNOLOGY Co.,Ltd. Country or region before: China |